Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles

Area of Science:

• Cardiovascular Medicine
• Mitochondrial Biology
• Pharmacology

Background:

• Mitochondrial dysfunction is implicated in numerous cardiovascular disorders.
• Significant research has explored mitochondria-targeted therapies for cardiovascular disease over the last 20 years.
• Currently, no drugs specifically designed to modulate mitochondrial function are approved for clinical cardiovascular management.

Purpose of the Study:

• To review the therapeutic potential of targeting mitochondria in cardiovascular disease.
• To examine the obstacles hindering the development of mitochondria-targeting agents.
• To identify strategies to realize the clinical potential of this therapeutic approach.

Main Methods:

• Literature review of studies on mitochondria-targeting agents for cardiovascular disease.
• Analysis of challenges in drug development for mitochondrial modulation.
• Exploration of potential strategies for future therapeutic advancements.

Main Results:

• Despite extensive research, no specific mitochondria-modulating drugs are clinically available for cardiovascular disease.
• Several obstacles have impeded the translation of promising research into clinical practice.
• The review identifies key areas and strategies for future development.

Conclusions:

• Targeting mitochondria remains a promising avenue for cardiovascular disease treatment.
• Overcoming current developmental hurdles is crucial for clinical success.
• Strategic advancements are needed to fully harness the therapeutic potential of mitochondria-based therapies.